POINT BIOPHARMA GLOBAL INC. Payments to Acquire Notes Receivable
POINT BIOPHARMA GLOBAL INC. reported Payments to Acquire Notes Receivable of $5.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireNotesReceivable · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. payments to acquire notes receivable for the quarter ending 2023-09-30 was $0.00.
- POINT BIOPHARMA GLOBAL INC. payments to acquire notes receivable for the quarter ending 2022-09-30 was $0.00.
| Period end | Payments to Acquire Notes Receivable | Payments to Acquire Notes Receivable 3 month | Payments to Acquire Notes Receivable 6 month | Payments to Acquire Notes Receivable 9 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.00M 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $5.00M 10-Q · filed 2023-08-14 | |||
| 2023-06-01 | $5.00M 10-Q · filed 2023-11-13 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 |